Institutional investors purchased a net $3.0 million shares of BGMD during the quarter ended March 2014 and now own 19.82% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UNITED BANK, INC. (PARKERSBURG, ... Bought 10.0 Thousand shares of BG Medicine Inc